Article info
PDFCommentary
General medicine
Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy
- Correspondence to Dr Robert W Yeh, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; Ryeh{at}bidmc.harvard.edu
Citation
Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy
Publication history
- Accepted January 25, 2018
- First published February 19, 2018.
Online issue publication
November 17, 2018
Article Versions
- Previous version (16 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.